SLU-PP-332
SLU-PP-332 is an investigational research compound, dispensed here as a 250mcg capsule, 90 per supply. Human data is very limited and it is not an FDA-approved product. It is prescribed only after a candid conversation with a licensed provider about the evidence.
Pharmacy shipping: $20 added once per medication order.
About this treatment
Explore a research pathway connected with exercise biology.
SLU-PP-332 is an investigational small molecule designed to study receptors that help regulate cellular energy use. Its research centers on muscle metabolism and exercise-related signaling. IAM lists a compounded capsule for a discussion of that research and your goals.
A receptor involved in cellular energy use
SLU-PP-332 acts on estrogen-related receptors, abbreviated ERRs. Despite the similar name, these are different from the usual estrogen receptors targeted in hormone treatment. ERRs regulate genes involved in mitochondrial function and energy metabolism, making them a research target for understanding how muscle responds to changing energy demands.
Why exercise appears in the research
Researchers use the term exercise mimetic for a compound designed to reproduce selected molecular signals associated with physical activity. SLU-PP-332 research examines those signals alongside fuel use, muscle characteristics and metabolic measures. Scientists are particularly interested in how ERR activation relates to the use of fats and carbohydrates for energy.
Keep the capsule and the goal in context
IAM lists an oral capsule. The published metabolic studies used a different research route, so ask how the exact preparation relates to the information available. Be clear about whether your concern is exercise tolerance, weight or a change in everyday activity, and discuss how that concern should be assessed before deciding on care.
Research and product information
The cited treatment research used cells and mice, not human clinical trials. It does not establish weight loss, fitness improvement, oral absorption or long-term safety for IAM's capsule. SLU-PP-332 is not FDA-approved and should not be described as a replacement for exercise.
- Billon et al. SLU-PP-332 and exercise-related ERR signaling in preclinical models (2023)
- Billon et al. ERR activation and metabolism in mouse models (2024)
Sources checked .
Your path to SLU-PP-332
Complete the assessment
Share your goals and health history in the patient portal.
Provider review
A licensed provider explains what is known and not known about this compound.
Care coordination
Your care team coordinates the prescription after provider approval.
About this treatment
What it is
A research compound dispensed as a compounded capsule. Human data is very limited, so it is prescribed conservatively and only after a full review.
Who it's for
Adults whose provider decides an investigational compound is appropriate, and who understand how limited the evidence is.
Forms we dispense
Capsule 250mcg
A licensed provider reviews your history and requests labs when clinically appropriate before prescribing.
Prescriptions are coordinated with our licensed US pharmacy partner, with dosing supplies included when needed.
We do not sell pharmaceuticals online. Every prescription comes after a full provider review.
